These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

450 related articles for article (PubMed ID: 21676904)

  • 1. Impact of guidelines and enhanced antibiotic stewardship on reducing broad-spectrum antibiotic usage and its effect on incidence of Clostridium difficile infection.
    Talpaert MJ; Gopal Rao G; Cooper BS; Wade P
    J Antimicrob Chemother; 2011 Sep; 66(9):2168-74. PubMed ID: 21676904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An evaluation of the impact of antibiotic stewardship on reducing the use of high-risk antibiotics and its effect on the incidence of Clostridium difficile infection in hospital settings.
    Aldeyab MA; Kearney MP; Scott MG; Aldiab MA; Alahmadi YM; Darwish Elhajji FW; Magee FA; McElnay JC
    J Antimicrob Chemother; 2012 Dec; 67(12):2988-96. PubMed ID: 22899806
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Successful use of feedback to improve antibiotic prescribing and reduce Clostridium difficile infection: a controlled interrupted time series.
    Fowler S; Webber A; Cooper BS; Phimister A; Price K; Carter Y; Kibbler CC; Simpson AJ; Stone SP
    J Antimicrob Chemother; 2007 May; 59(5):990-5. PubMed ID: 17387117
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of an intervention to control Clostridium difficile infection on hospital- and community-onset disease; an interrupted time series analysis.
    Price J; Cheek E; Lippett S; Cubbon M; Gerding DN; Sambol SP; Citron DM; Llewelyn M
    Clin Microbiol Infect; 2010 Aug; 16(8):1297-302. PubMed ID: 19832710
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of a national 4C antibiotic stewardship intervention on the clinical and molecular epidemiology of Clostridium difficile infections in a region of Scotland: a non-linear time-series analysis.
    Lawes T; Lopez-Lozano JM; Nebot CA; Macartney G; Subbarao-Sharma R; Wares KD; Sinclair C; Gould IM
    Lancet Infect Dis; 2017 Feb; 17(2):194-206. PubMed ID: 27825595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of fluoroquinolone restriction (from 2007 to 2012) on Clostridium difficile infections: interrupted time-series analysis.
    Sarma JB; Marshall B; Cleeve V; Tate D; Oswald T; Woolfrey S
    J Hosp Infect; 2015 Sep; 91(1):74-80. PubMed ID: 26169793
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cumulative antibiotic exposures over time and the risk of Clostridium difficile infection.
    Stevens V; Dumyati G; Fine LS; Fisher SG; van Wijngaarden E
    Clin Infect Dis; 2011 Jul; 53(1):42-8. PubMed ID: 21653301
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multihospital outbreak of Clostridium difficile ribotype 027 infection: epidemiology and analysis of control measures.
    Aldeyab MA; Devine MJ; Flanagan P; Mannion M; Craig A; Scott MG; Harbarth S; Vernaz N; Davies E; Brazier JS; Smyth B; McElnay JC; Gilmore BF; Conlon G; Magee FA; Elhajji FW; Small S; Edwards C; Funston C; Kearney MP
    Infect Control Hosp Epidemiol; 2011 Mar; 32(3):210-9. PubMed ID: 21460505
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of national antibiotic stewardship and infection control strategies on hospital-associated and community-associated meticillin-resistant Staphylococcus aureus infections across a region of Scotland: a non-linear time-series study.
    Lawes T; Lopez-Lozano JM; Nebot CA; Macartney G; Subbarao-Sharma R; Dare CR; Wares KD; Gould IM
    Lancet Infect Dis; 2015 Dec; 15(12):1438-49. PubMed ID: 26411518
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluating the Effectiveness of an Antimicrobial Stewardship Program on Reducing the Incidence Rate of Healthcare-Associated Clostridium difficile Infection: A Non-Randomized, Stepped Wedge, Single-Site, Observational Study.
    DiDiodato G; McArthur L
    PLoS One; 2016; 11(6):e0157671. PubMed ID: 27309536
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of interventions to reduce the incidence of Clostridium difficile infection at a London teaching hospital trust, 2003-2011.
    Marufu O; Desai N; Aldred D; Brown T; Eltringham I
    J Hosp Infect; 2015 Jan; 89(1):38-45. PubMed ID: 25480022
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modified guidelines impact on antibiotic use and costs: duration of treatment for pneumonia in a neurosurgical ICU is reduced.
    Meyer E; Buttler J; Schneider C; Strehl E; Schroeren-Boersch B; Gastmeier P; Ruden H; Zentner J; Daschner FD; Schwab F
    J Antimicrob Chemother; 2007 Jun; 59(6):1148-54. PubMed ID: 17434880
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence of Clostridium difficile infections in patients receiving antimicrobial and acid-suppression therapy.
    King RN; Lager SL
    Pharmacotherapy; 2011 Jul; 31(7):642-8. PubMed ID: 21923450
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of continued antibacterial therapy after diagnosis of hospital-onset Clostridium difficile infection: implications for antimicrobial stewardship.
    Harpe SE; Inocencio TJ; Pakyz AL; Oinonen MJ; Polk RE
    Pharmacotherapy; 2012 Aug; 32(8):744-54. PubMed ID: 23307522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Community-associated Clostridium difficile infection and antibiotics: a meta-analysis.
    Deshpande A; Pasupuleti V; Thota P; Pant C; Rolston DD; Sferra TJ; Hernandez AV; Donskey CJ
    J Antimicrob Chemother; 2013 Sep; 68(9):1951-61. PubMed ID: 23620467
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fluoroquinolone use and risk factors for Clostridium difficile-associated disease within a Veterans Administration health care system.
    McFarland LV; Clarridge JE; Beneda HW; Raugi GJ
    Clin Infect Dis; 2007 Nov; 45(9):1141-51. PubMed ID: 17918075
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparative study of three methods to evaluate an intervention to improve empirical antibiotic therapy for acute bacterial infections in hospitalized patients.
    Schön T; Sandelin LL; Bonnedahl J; Hedebäck F; Wistedt A; Brudin L; Jarnheimer PÅ
    Scand J Infect Dis; 2011 Apr; 43(4):251-7. PubMed ID: 21171827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Successful combat of an outbreak due to Clostridium difficile PCR ribotype 027 and recognition of specific risk factors.
    Debast SB; Vaessen N; Choudry A; Wiegers-Ligtvoet EA; van den Berg RJ; Kuijper EJ
    Clin Microbiol Infect; 2009 May; 15(5):427-34. PubMed ID: 19416295
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Time interval of increased risk for Clostridium difficile infection after exposure to antibiotics.
    Hensgens MP; Goorhuis A; Dekkers OM; Kuijper EJ
    J Antimicrob Chemother; 2012 Mar; 67(3):742-8. PubMed ID: 22146873
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Community-associated Clostridium difficile infection among older people in Tayside, Scotland, is associated with antibiotic exposure and care home residence: cohort study with nested case-control.
    Marwick CA; Yu N; Lockhart MC; McGuigan CC; Wiuff C; Davey PG; Donnan PT
    J Antimicrob Chemother; 2013 Dec; 68(12):2927-33. PubMed ID: 23825381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.